{"id":1028,"date":"2014-10-05T20:46:45","date_gmt":"2014-10-06T00:46:45","guid":{"rendered":"http:\/\/allphasepharma.com\/dir\/?p=1028"},"modified":"2015-12-24T16:59:33","modified_gmt":"2015-12-24T21:59:33","slug":"qidp-drugs-here-they-are-all-of-them","status":"publish","type":"post","link":"https:\/\/allphasepharma.com\/dir\/2014\/10\/05\/1028\/qidp-drugs-here-they-are-all-of-them\/","title":{"rendered":"QIDP Drugs: Here They Are, All of Them"},"content":{"rendered":"<h3 style=\"text-align: center;\"><strong>For the latest QIDP listing, please click <a href=\"https:\/\/allphasepharma.com\/dir\/2015\/12\/23\/2205\/qidp-antibiotics-2015-year-end-update\/\">HERE<\/a><\/strong><\/h3>\n<hr \/>\n<h3 style=\"text-align: center;\"><\/h3>\n<p>As of Oct. 9, 2014, there were by my accounting 30 compounds with QIDP designation. <a href=\"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/10\/Pivot-new-copy.jpg?ssl=1\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-1058\" src=\"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/10\/Pivot-new-copy.jpg?resize=530%2C190&#038;ssl=1\" alt=\"Pivot-new copy\" width=\"530\" height=\"190\" srcset=\"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/10\/Pivot-new-copy.jpg?w=673&amp;ssl=1 673w, https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/10\/Pivot-new-copy.jpg?resize=300%2C107&amp;ssl=1 300w\" sizes=\"auto, (max-width: 530px) 100vw, 530px\" \/><\/a>Here is the break-down:<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li>31 compounds with QIDP designation<\/li>\n<li>29 antibacterials, 2 \u00a0antifungals<\/li>\n<li>22 systemically active, 9\u00a0for topical administration<\/li>\n<li>13 in Phase 3, 9 in Phase 2, and 5\u00a0in Phase 1<\/li>\n<li>26 from known drug classes, 5 are NCEs<\/li>\n<\/ul>\n\n<table id=\"tablepress-10\" class=\"tablepress tablepress-id-10\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Company<\/th><th class=\"column-2\">Drug Name<\/th><th class=\"column-3\">Antibiotic Class<\/th><th class=\"column-4\">Phase<\/th><th class=\"column-5\">Action Site<\/th><th class=\"column-6\">Antimicrobial_Class<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Achaogen<\/td><td class=\"column-2\">Plazomicin<\/td><td class=\"column-3\">aminoglycoside<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">Actavis<\/td><td class=\"column-2\">Avarofloxacin<\/td><td class=\"column-3\">quinolone<\/td><td class=\"column-4\">Phase 2<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Actavis<\/td><td class=\"column-2\">Ceftazidime + avibactam<\/td><td class=\"column-3\">B-lactam \/ BLI<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">Actelion Pharmaceuticals<\/td><td class=\"column-2\">Cadazolid<\/td><td class=\"column-3\">oxazolidinone<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">GI only<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Aradigm Pharmaceuticals<\/td><td class=\"column-2\">Ciprofloxacin<\/td><td class=\"column-3\">quinolone<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">pulmonary<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">AstraZeneca<\/td><td class=\"column-2\">AZD-0914<\/td><td class=\"column-3\">quinolone<\/td><td class=\"column-4\">Pre-Clin<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">Basilea Pharmaceutica<\/td><td class=\"column-2\">isavuconazole<\/td><td class=\"column-3\">azole<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antifungal<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">Cardeas Pharma<\/td><td class=\"column-2\">Amikacin + fosfomycin<\/td><td class=\"column-3\">aminoglycoside<\/td><td class=\"column-4\">Phase 2<\/td><td class=\"column-5\">pulmonary<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">Cempra Pharmaceuticals<\/td><td class=\"column-2\">Fusidic Acid<\/td><td class=\"column-3\">fusidic acid<\/td><td class=\"column-4\">Phase 2<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">Cempra Pharmaceuticals<\/td><td class=\"column-2\">Solithromycin<\/td><td class=\"column-3\">macrolide \/ ketolide<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">Cubist Pharmaceuticals<\/td><td class=\"column-2\">Surotomycin<\/td><td class=\"column-3\">glycopeptide<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">GI only<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">Cubist Pharmaceuticals<\/td><td class=\"column-2\">Tedizolid<\/td><td class=\"column-3\">oxazolidinone<\/td><td class=\"column-4\">Approved US<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">Cubist Pharmaceuticals<\/td><td class=\"column-2\">Ceftolozane + tazobactam<\/td><td class=\"column-3\">B-lactam \/ BLI<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\">Durata Therapeutics<\/td><td class=\"column-2\">Dalbavancin<\/td><td class=\"column-3\">glycopeptide<\/td><td class=\"column-4\">Approved US<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-16\">\n\t<td class=\"column-1\">Insmed Pharmaceuticals<\/td><td class=\"column-2\">Arikace<\/td><td class=\"column-3\">aminoglycoside<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">pulmonary<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-17\">\n\t<td class=\"column-1\">Melinta Therapeutics<\/td><td class=\"column-2\">Delafloxacin<\/td><td class=\"column-3\">quinolone<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-18\">\n\t<td class=\"column-1\">Melinta Therapeutics<\/td><td class=\"column-2\">Radezolid<\/td><td class=\"column-3\">oxazolidinone<\/td><td class=\"column-4\">Phase 2<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-19\">\n\t<td class=\"column-1\">Merck<\/td><td class=\"column-2\">Imipenem\/cilastatin + MK-7655<\/td><td class=\"column-3\">B-lactam \/ BLI<\/td><td class=\"column-4\">Phase 2<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-20\">\n\t<td class=\"column-1\">MerLion Pharmaceuticals<\/td><td class=\"column-2\">Finafloxacin<\/td><td class=\"column-3\">quinolone<\/td><td class=\"column-4\">Phase 2<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-21\">\n\t<td class=\"column-1\">Microbion Corporation<\/td><td class=\"column-2\">BisEDT Antimicrobial Gel<\/td><td class=\"column-3\">other<\/td><td class=\"column-4\">Phase 1<\/td><td class=\"column-5\">topical<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-22\">\n\t<td class=\"column-1\">Nabriva Therapeutics<\/td><td class=\"column-2\">BC-3781<\/td><td class=\"column-3\">pleuromutilin<\/td><td class=\"column-4\">Phase 2<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-23\">\n\t<td class=\"column-1\">Paratek Pharmaceuticals<\/td><td class=\"column-2\">Omadacycline<\/td><td class=\"column-3\">tetracycline<\/td><td class=\"column-4\">Phase 2<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-24\">\n\t<td class=\"column-1\">Scynexis Pharmaceuticals<\/td><td class=\"column-2\">SCY-078<\/td><td class=\"column-3\">other<\/td><td class=\"column-4\">Phase 1<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-25\">\n\t<td class=\"column-1\">Summit plc<\/td><td class=\"column-2\">SMT-19969<\/td><td class=\"column-3\">other<\/td><td class=\"column-4\">Phase 2<\/td><td class=\"column-5\">GI only<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-26\">\n\t<td class=\"column-1\">TaiGen Biotechnology<\/td><td class=\"column-2\">Nemonoxacin<\/td><td class=\"column-3\">quinolone<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-27\">\n\t<td class=\"column-1\">Tetraphase Pharmaceuticals<\/td><td class=\"column-2\">Eravacycline<\/td><td class=\"column-3\">tetracycline<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-28\">\n\t<td class=\"column-1\">The Medicines Company<\/td><td class=\"column-2\">Oritavancin<\/td><td class=\"column-3\">glycopeptide<\/td><td class=\"column-4\">Approved US<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-29\">\n\t<td class=\"column-1\">The Medicines Company<\/td><td class=\"column-2\">Meropenem + RPX7009<\/td><td class=\"column-3\">B-lactam \/ BLI<\/td><td class=\"column-4\">Phase 3<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-30\">\n\t<td class=\"column-1\">Valley Fever Solutions<\/td><td class=\"column-2\">NikZ<\/td><td class=\"column-3\">other<\/td><td class=\"column-4\">Phase 1<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antifungal<\/td>\n<\/tr>\n<tr class=\"row-31\">\n\t<td class=\"column-1\">Wockhardt Pharmaceuticals<\/td><td class=\"column-2\">WCK-771<\/td><td class=\"column-3\">quinolone<\/td><td class=\"column-4\">Phase 1<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<tr class=\"row-32\">\n\t<td class=\"column-1\">Wockhardt Pharmaceuticals<\/td><td class=\"column-2\">WCK-2349<\/td><td class=\"column-3\">quinolone<\/td><td class=\"column-4\">Phase 1<\/td><td class=\"column-5\">systemic<\/td><td class=\"column-6\">antibacterial<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-10 from cache -->\n<p>NOTE: Nabriva&#8217;s Lefamulin \/\u00a0BC-3781 just rec&#8217;d QIDP status and is included in the tables above. This systemic pleuromutilin has completed Phase 2 and is &#8220;ready for Phase 3&#8221;.<\/p>\n<p>NOTE: \u00a0Debio-1450 (the prodrug of Debio-1452 aka AFN-1252) should be added to the list. \u00a0Formerly developed by Affinium, this novel FabI antibiotic is in Phase 1 development as a prodrug, and in Phase 2 as the original Debio-1452. \u00a0The target of this class of fatty acid synthesis inhibitors is enoyl-acyl carrier protein reductase (ENR). The agent has a narrow spectrum of activity limited almost exclusively to staphylococci and enterococci.<\/p>\n<p>NOTE:\u00a0Cellceutix&#8217; Brilacidin has been granted QIDP status Dec. 8th, 2014. \u00a0This defensin-mimetic was formerly a\u00a0Polymedx drug; it is being developed for ABSSSI and now in Phase 2.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>For the latest QIDP listing, please click HERE As of Oct. 9, 2014, there were by my accounting 30 compounds with QIDP designation. Here is the break-down: &nbsp; 31 compounds with QIDP designation 29 antibacterials, 2 \u00a0antifungals 22 systemically active, 9\u00a0for topical administration 13 in Phase 3, 9 in Phase <a class=\"more-link\" href=\"https:\/\/allphasepharma.com\/dir\/2014\/10\/05\/1028\/qidp-drugs-here-they-are-all-of-them\/\">Continue reading <span class=\"screen-reader-text\">  QIDP Drugs: Here They Are, All of Them<\/span><span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":1038,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[140,3],"tags":[874,876,877,875,878,245,117],"class_list":["post-1028","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-interesting_facts","category-the_news","tag-brilacidin","tag-cellceutix","tag-debio","tag-defensin-mimetic","tag-lefamulin","tag-nabriva","tag-pleuromutilin"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/10\/APPC-QIDP-copy.jpg?fit=640%2C200&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/p4KWFr-gA","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":1800,"url":"https:\/\/allphasepharma.com\/dir\/2015\/08\/01\/1800\/qidp-drugs-4th-edition\/","url_meta":{"origin":1028,"position":0},"title":"QIDP Drugs &#8211;  4th Edition","author":"Harald","date":"August 1, 2015","format":false,"excerpt":">>> For the latest QIDP list, please click HERE \u00a0<<< Since our\u00a0last QIDP blog from April 8, 2015, several new drugs have made the list which now includes 41 compounds. Below a table\u00a0which includes compound, sponsor\u00a0and development stage (Phase). It also indicates whether a drug has been\u00a0the topic of a\u2026","rel":"","context":"In &quot;Recent Literature&quot;","block_context":{"text":"Recent Literature","link":"https:\/\/allphasepharma.com\/dir\/category\/recent_literature\/"},"img":{"alt_text":"QIDP 4th edition","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2015\/08\/QIDP-4th-edition.jpg?resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2015\/08\/QIDP-4th-edition.jpg?resize=350%2C200 1x, https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2015\/08\/QIDP-4th-edition.jpg?resize=525%2C300 1.5x"},"classes":[]},{"id":157,"url":"https:\/\/allphasepharma.com\/dir\/2014\/04\/22\/157\/antibiotics-with-qidp-designation\/","url_meta":{"origin":1028,"position":1},"title":"Antibiotics with QIDP Designation &#8211;   &#8211;    &#8211;  Updated 9-30-14","author":"Harald","date":"April 22, 2014","format":false,"excerpt":"For the latest QIDP listing, please click HERE \u00a0 Since\u00a0FDA issued the QIDP designation in 2012, many companies have requested this important 'label'. \u00a0Which should not come as a surprise: QIDP status confers significant benefits - and there is no downside. While an official FDA list of drugs that have\u2026","rel":"","context":"In &quot;QIDP Antibiotics&quot;","block_context":{"text":"QIDP Antibiotics","link":"https:\/\/allphasepharma.com\/dir\/category\/qidp_antibiotic\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/04\/FDA-GAIN-LPAD-banner-copy.jpg?fit=640%2C200&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/04\/FDA-GAIN-LPAD-banner-copy.jpg?fit=640%2C200&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/04\/FDA-GAIN-LPAD-banner-copy.jpg?fit=640%2C200&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":2817,"url":"https:\/\/allphasepharma.com\/dir\/2016\/10\/24\/2817\/qidp-drug-update-part-2-categories-of-interest\/","url_meta":{"origin":1028,"position":2},"title":"QIDP Drug Update \u2013 Part 2: \u00a0Categories of Interest","author":"Harald","date":"October 24, 2016","format":false,"excerpt":"According to Janet Woodcock, 63 drugs have been given the \u201cQIDP\u201d designation so far. Our inofficial list has 61 drugs, of which we believe only 57 are still in active clinical development.\u00a0 So we are in fairly close agreement. That may seem like an impressive record but it is also\u2026","rel":"","context":"In &quot;QIDP Antibiotics&quot;","block_context":{"text":"QIDP Antibiotics","link":"https:\/\/allphasepharma.com\/dir\/category\/qidp_antibiotic\/"},"img":{"alt_text":"qidp-part2-slider","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2016\/10\/QIDP-Part2-slider.jpg?resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2016\/10\/QIDP-Part2-slider.jpg?resize=350%2C200 1x, https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2016\/10\/QIDP-Part2-slider.jpg?resize=525%2C300 1.5x"},"classes":[]},{"id":2205,"url":"https:\/\/allphasepharma.com\/dir\/2015\/12\/23\/2205\/qidp-antibiotics-2015-year-end-update\/","url_meta":{"origin":1028,"position":3},"title":"QIDP Antibiotics  &#8211;  2015 Year-End Update","author":"Harald","date":"December 23, 2015","format":false,"excerpt":"Here an updated listing of all QIDP drugs we are aware of as of 12\/24\/2015. Today just\u00a0facts and numbers; we will provide an interpretation of the current landscape in upcoming blogs. There are\u00a058 drugs which garnered QIDP status and these are listed in the Main Table below. With the recent\u2026","rel":"","context":"In &quot;QIDP Antibiotics&quot;","block_context":{"text":"QIDP Antibiotics","link":"https:\/\/allphasepharma.com\/dir\/category\/qidp_antibiotic\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2015\/12\/QIDP-slider.jpg?fit=640%2C200&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2015\/12\/QIDP-slider.jpg?fit=640%2C200&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2015\/12\/QIDP-slider.jpg?fit=640%2C200&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":1332,"url":"https:\/\/allphasepharma.com\/dir\/2015\/03\/28\/1332\/drugs-with-qidp-designation-update-3282015\/","url_meta":{"origin":1028,"position":4},"title":"Drugs with QIDP Designation \u2013 Update 4\/8\/2015","author":"Harald","date":"March 28, 2015","format":false,"excerpt":"For the latest QIDP listing, please click HERE Our latest internet search came up with 37 drugs that garnered QIDP status.\u00a0 They are listed in the Table below (if I missed a compound, please leave a comment!!). \u00a0The\u00a0table is searchable so you should be able to massage the data to\u2026","rel":"","context":"In &quot;QIDP Antibiotics&quot;","block_context":{"text":"QIDP Antibiotics","link":"https:\/\/allphasepharma.com\/dir\/category\/qidp_antibiotic\/"},"img":{"alt_text":"APPC + QIDP copy","src":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/10\/APPC-QIDP-copy.jpg?resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/10\/APPC-QIDP-copy.jpg?resize=350%2C200 1x, https:\/\/i0.wp.com\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/10\/APPC-QIDP-copy.jpg?resize=525%2C300 1.5x"},"classes":[]},{"id":517,"url":"https:\/\/allphasepharma.com\/dir\/2014\/07\/05\/517\/bc-3781-passes-phase-2-with-flying-colors-readies-for-phase-3\/","url_meta":{"origin":1028,"position":5},"title":"BC-3781 Passes Phase 2 with Flying Colors, Readies for Phase 3","author":"Harald","date":"July 5, 2014","format":false,"excerpt":"The pleuromutilins are a relatively \u2018old\u2019 class of antibiotics that have seen much use in veterinary but not in human medicine.\u00a0 According to EMA, Tiamulin is an \u201cessential antibiotic\u201d for the control of dysentery in pigs which is caused by Brachyspira hyodysenteriae, a macrolide-resistant pathogen.[1]\u00a0 Retapamulin \/ Altabax\u00ae was introduced\u2026","rel":"","context":"In &quot;QIDP Antibiotics&quot;","block_context":{"text":"QIDP Antibiotics","link":"https:\/\/allphasepharma.com\/dir\/category\/qidp_antibiotic\/"},"img":{"alt_text":"pleuromutilin1","src":"http:\/\/allphasepharma.com\/dir\/wp-content\/uploads\/2014\/07\/pleuromutilin1.jpe","width":350,"height":200},"classes":[]}],"jetpack_likes_enabled":true,"_links":{"self":[{"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/posts\/1028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/comments?post=1028"}],"version-history":[{"count":21,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/posts\/1028\/revisions"}],"predecessor-version":[{"id":2229,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/posts\/1028\/revisions\/2229"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/media\/1038"}],"wp:attachment":[{"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/media?parent=1028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/categories?post=1028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/allphasepharma.com\/dir\/wp-json\/wp\/v2\/tags?post=1028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}